Sandra Mazzoni, DO, a hematologist at Cleveland Clinic Taussig Cancer Institute joins the Cancer Advances podcast to talk about monoclonal gammopathy of undetermined significance, known as MGUS. Listen as Dr. Mazzoni talks about this abnormal protein and explains when we can still effectively treat patients before it hits all the criteria for becoming multiple myeloma ..read more

Radiation Oncologist, Physician Scientist, and Founding Director of the Center for Hyperthermia at Cleveland Clinic, Jennifer Yu, MD, PhD, joins the Cancer Advances podcast to discuss hyperthermia therapy, which uses heat to destroy cancer cells and shrink tumors. Listen as Dr. Yu explains how this therapy works; and how it helps radiation and chemotherapy treatments become more effective for patients ..read more

Alex A. Adjei, MD, PhD, Chair of Cleveland Clinic Taussig Cancer Institute, joins the Cancer Advances podcast to discuss the new Novel Therapeutics Clinic. Listen as Dr. Adjei shares the importance of novel cancer therapetuics, how the clinic is structured, and his hopes of having multiple treatment options for every cancer ..read more

Arun D. Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, and Stacey Zahler, DO, a pediatric hematologist-oncologist at Cleveland Clinic Children's join the Cancer Advances podcast to discuss retinoblastoma. Listen as they discuss this unique children's eye cancer, the treatment options available, and the genetic counseling we have at Cleveland Clinic ..read more

Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute specializing in head and neck cancers, joins the Cancer Advances podcast to discuss new ASCO guidelines for recurrent and metastatic head and neck cancers. Listen as Dr. Yilmaz explains how the guidelines focus on biomarkers, tumor mutation burdens, and how they will impact patient care ..read more

Aaron Gerds, MD, MS, a hematologist in Cleveland Clinic Cancer Center’s Leukemia and Myeloid Disorders Program and Deputy Director for Clinical Research at the Taussig Cancer Institute joins the Cancer Advances podcast to talk about the MOMENTUM trial that was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Gerds discusses myelofibrosis, the differences between the trial results from 24 to 48 weeks, and the exciting new approaches that are coming to the field ..read more

Hermann Kessler, MD, PhD, a senior colorectal surgeon in the Department of Colorectal Surgery, joins the Cancer Advances podcast to talk about the benefits of a complete mesocolic excision (CME) for patients with colon cancer. Listen as Dr. Kessler talks about improving survival and local recurrence rates, the importance of screening programs, and incorporating different modalities into surgery ..read more

The Cancer Advances podcast is joined by Kate Eshleman, PsyD, a pediatric psychologist in the Center for Pediatric Behavioral Health at Cleveland Clinic Children's to talk about the mental health of children and teenagers with cancer. Listen as Dr. Eshleman discusses the Cleveland Clinic Children's survivorship program, what medical professionals should watch out for, and how to assist patient families ..read more

Chair of the Department of Gastroenterology, Hepatology, and Nutrition, Michelle Kang Kim, MD, PhD, joins the Cancer Advances podcast to discuss neuroendocrine tumors. Listen as Dr. Kim talks about creating a database of biomarker studies, the use of DOTATATE PET CT imaging, and the collaborative, multi-disciplinary approach taken at Cleveland Clinic to treat neuroendocrine tumors ..read more

Christopher Weight, MD, Center Director of Urologic Oncology at Cleveland Clinic joins the Cancer Advances podcast to discuss using artificial intelligence to diagnose kidney cancer. Listen as Dr. Weight explains the progress we have made with imaging-generated software and a fully automated equivalent nephrometry score ..read more